Risk factors for race-associated sudden death in Thoroughbred racehorses in the UK (2000-2007).

Equine Vet J

Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.

Published: July 2012

Reasons For Performing Study: Sudden death adversely affects racehorse welfare, jockey safety and the public perception of horseracing.

Objective: To describe the risk of racing-associated sudden death in Thoroughbred racehorses in the UK from 2000 to 2007, to identify whether there were risk factors uniquely associated with sudden death and to improve the understanding of the pathogenesis of racing-associated sudden death by identification of risk factors for such cases.

Methods: A sudden death was defined as an acute collapse and death, in an apparently healthy Thoroughbred racehorse, during or immediately after racing, in the absence of clinical data indicative of a catastrophic orthopaedic injury. The retrospective study included 201 case race starts and 705,712 control race starts. Univariable and multivariable logistic regression were used to identify risk factors for sudden death at any one start.

Results: In the multivariable model, age, distance, race type, season and number of starts in the 60 days prior to the race were associated with sudden death.

Conclusions: The risk factors identified in this study are not uniquely associated with sudden death and have been also been identified in studies using all causes of fatality as the outcome. These data suggest that a generic approach to reduce fatal musculoskeletal injury and sudden death may be possible.

Potential Relevance: The identification of risk factors allows speculation on the underlying mechanisms of sudden death in racing. This may stimulate hypothesis-led investigations into the pathogenesis of exercise-related arrhythmias, exercise-induced pulmonary haemorrhage and blood vessel rupture.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.2042-3306.2011.00496.xDOI Listing

Publication Analysis

Top Keywords

sudden death
40
risk factors
24
associated sudden
12
sudden
11
death
11
death thoroughbred
8
thoroughbred racehorses
8
racing-associated sudden
8
identify risk
8
uniquely associated
8

Similar Publications

Background: Ventricular tachycardia (VT) in patients with cardiac sarcoidosis (CS) can lead to sudden cardiac death. The role of ventricular tachycardia ablation (VTA) in CS has been investigated in a few small, single-center, and larger observational studies, but the evidence still needs to be provided. This study aimed to investigate the clinical outcomes of VTA in patients with CS admitted with a diagnosis of VT.

View Article and Find Full Text PDF

Background: Cardiac sarcoidosis (CS) is associated with poor prognosis, making early diagnosis and treatment important. This study evaluated the results of a diagnostic approach in patients with known sarcoidosis and suspected cardiac involvement in a tertiary centre and their long-term outcomes.

Methods: We included 180 patients with sarcoidosis and a clinical suspicion of CS.

View Article and Find Full Text PDF

Background: N-terminal brain natriuretic peptide (NTproBNP) is a marker of cardiac health and a strong predictor of mortality, incident cardiovascular disease (CVD), and sudden cardiac death in community populations. A link between the menopause transition (MT), sex hormones, and NTproBNP has been suggested, though, no studies have formally examined how NTproBNP changes over the MT. In addition of being a marker of cardiac health, studies suggest NTproBNP to be related to cognitive performance, yet those studies have not considered the MT.

View Article and Find Full Text PDF

Background: When treatments against neurodegenerative diseases eventuate, the most successful time point to administer therapies will be the early stages, most likely before symptoms begin to show. Previous studies have found alpha-synuclein pathology (Lewy-related pathology; LRP) in asymptomatic individuals aged 62 years and above, with ranges from 8 to 17%.

Method: We performed immunohistochemical staining with the 5G4 antibody against alpha-synuclein on brain tissue samples from the Tampere Sudden Death Study - a collection of forensic autopsies on individuals that lived outside hospital institutions in Tampere and the surrounding regions, Finland.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!